cjc-1295 with dac and ipamorelin & Blend (10mg) CJC-1295 (No DAC) 5mg, Ipamorelin
Description
Guitera P, Li LX, Scolyer RA, Menzies SW
335,336 First reported as the first reversible METAP inhibitor (METAPi) in 2003, LAF389 is a natural benzimide compound with dual METAP 1i and METAP 2i activities
Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review
If calculated concentration differs from intended, adjust dose draw volume to maintain microgram delivery accuracy rather than discarding the vial
doi: 10.1093/hmg/ddt242
